bioMerieux (BIM.PA) stock price, revenue, and financials

bioMerieux market cap is €11.7 b, and annual revenue was €2.1 b in FY 2016

€11.7 B

BIM.PA Mkt cap, 15-Oct-2021

€2.1 B

bioMerieux Revenue FY, 2016
bioMerieux Revenue growth (FY, 2015 - FY, 2016), %7%
bioMerieux Gross profit (FY, 2016)1.1 B
bioMerieux Gross profit margin (FY, 2016), %52.3%
bioMerieux Net income (FY, 2016)179.2 M
bioMerieux EBIT (FY, 2016)282.5 M
bioMerieux Cash, 31-Dec-2016178.6 M
bioMerieux EV12 B
Get notified regarding key financial metrics and revenue changes at bioMerieuxLearn more
Banner background

bioMerieux Revenue

bioMerieux revenue was €2.1 b in FY, 2016 which is a 7.1% year over year increase from the previous period.

Embed Graph

bioMerieux Income Statement

Annual

EURFY, 2014FY, 2015FY, 2016

Revenue

1.7b2.0b2.1b

Revenue growth, %

16%7%

Cost of goods sold

853.9m975.4m1.0b

Gross profit

844.5m989.2m1.1b

Gross profit Margin, %

50%50%52%

Sales and marketing expense

311.3m365.4m402.1m

R&D expense

205.8m238.9m271.9m

General and administrative expense

141.7m163.8m167.4m

Operating expense total

658.8m768.1m841.4m

EBIT

203.6m194.9m282.5m

EBIT margin, %

12%10%13%

Interest expense

7.2m24.6m17.6m

Income tax expense

51.7m65.9m79.8m

Net Income

135.5m110.3m179.2m

bioMerieux Balance Sheet

Annual

EURFY, 2014FY, 2015FY, 2016

Cash

119.7m147.1m178.6m

Accounts Receivable

449.3m445.1m465.8m

Inventories

299.2m355.8m404.4m

Current Assets

991.4m1.1b1.2b

PP&E

486.9m573.6m734.5m

Goodwill

437.8m459.3m470.6m

Total Assets

2.6b2.8b3.0b

Accounts Payable

188.9m176.9m175.6m

Short-term debt

63.5m61.8m87.9m

Current Liabilities

611.5m683.5m759.8m

Long-term debt

305.7m308.9m365.4m

Non-Current Liabilities

556.2m582.0m647.6m

Total Debt

369.2m370.7m453.3m

Common Stock

12.0m12.0m12.0m

Additional Paid-in Capital

1.2b1.4b1.4b

Total Equity

1.4b1.5b1.6b

Debt to Equity Ratio

0.3 x0.2 x0.3 x

Debt to Assets Ratio

0.1 x0.1 x0.1 x

Financial Leverage

1.9 x1.8 x1.9 x

bioMerieux Cash Flow

Annual

EURFY, 2014FY, 2015FY, 2016

Net Income

135.5m110.3m179.2m

Cash From Operating Activities

298.3m310.0m335.6m

Purchases of PP&E

(158.1m)(208.2m)(233.0m)

Cash From Investing Activities

(502.7m)(208.0m)(257.2m)

Cash From Financing Activities

(83.4m)(62.1m)(52.5m)

bioMerieux Ratios

EURFY, 2014

Debt/Equity

0.3 x

Debt/Assets

0.1 x

Financial Leverage

1.9 x

bioMerieux Operating Metrics

FY, 2015FY, 2016

Countries

150

Facilities

19

Patents and Patent Applications

581529

bioMerieux Employee Rating

4.2567 votes
Culture & Values
4.4
Work/Life Balance
4.1
Senior Management
4
Salary & Benefits
4
Career Opportunities
3.8
Source